Stryker Corp. (NYSE:SYK) inked new deals for its joint preservation arm and its interventional spine division this week. The Kalamazoo, Mich.-based company added its inflatable vertebral augmentation system (iVAS) to its national agreement with supply contracting company Novation LLC. The deal makes Stryker the single source for balloon-assisted spine augmentation for health care groups UHC, […]
Stryker Corp. (NYSE:SYK) is fielding legal challenges on two fronts, one from a former distributor and DePuy Spine and another from a Utah man claiming a Stryker pain pump destroyed his shoulder. DePuy and BioInitiatives Inc., a former Stryker Spine distributor, asked a California judge for an injunction barring Stryker from enforcing a non-competition clause […]
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
Michael Mogul, the head of Stryker Corp.’s (NYSE:SYK) $4-billion-plus orthopedics division, is off to greener pastures: The corner office at DJO Global Inc. Mogul, 46, was with Stryker for most of his professional life. He joined the Kalamazoo, Mich.-based medical device giant in 1989 when he was just 24 years old and worked his way […]
Shareholders of Orthovita Inc. (NSDQ: VITA), a Malvern, Pa.-based orthopedic biologics maker, are suing over a proposed $316 million merger by Stryker Corp. (NYSE:SYK ) that represents a hefty percent premium on VITA stock price. The stockholders, led by Andrew Thorn, accused the two companies and Orthovita’s board of breaching its fiduciary duty in agreeing […]
Stryker Corp. (NYSE: SYK ) CEO Stephen MacMillan took time out to tout his company’s resilience at an analyst meeting in New York Wednesday. MacMillan said the Kalamazoo, Mich.-based orthopedic and medical equipment giant has proven its mettle in tough times, something he said would allow it to continue to perform, despite struggles in the […]
Stryker Corp. CEO Stephen MacMillan ceded another pay raise last year, citing the “challenging business environment” and leaving the orthopedics giant’s top boss at 2008 base pay levels. Stryker Corp. (NYSE: SYK ) CEO Stephen MacMillan once again deferred a pay raise in 2010 due to the “challenging business environment,” despite increasing the company’s bottom […]
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.
The Stryker lawsuit claims the company improperly promoted off-label use of a pair of bone-growth products and also lied to the Food & Drug Administration. Stryker Biotech now says the government is over-reaching with its indictment and failing to back up most of its charges.
Stryker Corp. (NYSE:SYK) filed a patent infringement lawsuit this week against Zimmer Holdings Inc. (NYSE:ZMH) over a trio of wound-care device patents. The lawsuit, filed in the U.S. District Court for Western New York, accuses Warsaw, Indiana-based Zimmer of violating the patents — “Irrigation handpiece with built in pulsing pump,” “Surgical/medical irrigator with removable tip […]
The U.S. Constitution's Commerce Clause states that Congress has the power to "regulate Commerce … among the several States." To supporters of health reform, the Commerce Clause is the Grinch that stole Obamacare, writes the Health Care Blog. To opponents, it might seem like a Sanity Clause.
Orthopedics company Stryker Corp. (NYSE:SYK) has agreed to sell a product line including the bone growth putty that has caused the company so much legal grief to Olympus Corp. for $60 million. Kalamazoo, Michigan-based Stryker plans to record a loss on the sale of its OP-1 product line of between $75 million and $80 million.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Boston Scientific Corp. (NYSE:BSX) CEO Ray Elliott is making good on his promise to more aggressively pursue deals. His company, based in Natick, Massachusetts but with major operations in Minnesota, said it will purchase replacement heart valve maker Sadra Medical Inc. for as much as $386 million. Under terms of the deal, Boston Scientific will […]
Federal prosecutors blasted Stryker Corp.’s (NYSE:SYK) biotech subsidiary, its former president and three sales reps for seeking the dismissal of the bulk of the 16 criminal charges pending against them in a federal case alleging the illegal promotion of bone putties. Hopkinton, Mass.-based Stryker Biotech, former president Mark Philip and the sales reps — national […]
I've devoted plenty of Internet ink to the diverging fortunes of St. Jude Medical Inc. (NYSE:STJ) and Boston Scientific Corp. (NYSE:BSX). Apparently other people see the same thing.
Boston Scientific Corp. (NYSE:BSX) finally pulled the trigger Thursday, saying it would sell a major business to Stryker Corp. It just wasn't the business Wall Street was expecting it to sell.
The CEOs of three medical device makers sat down for a round-table discussion of the challenges and opportunities facing the industry at the annual AdvaMed MedTech conference in Washington, D.C. William Hawkins of Medtronic Inc. (NYSE:MDT), Stephen MacMillan of Stryker Corp. (NYSE:SYK) and Michael Minogue of Abiomed Inc. (NASDAQ:ABMD) spoke about upcoming changes to the 510(k) protocol, the user fee program, transparency initiatives and the steps they're taking to deal with healthcare reform.